Accuray Inc (ARAY) stock
ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
$2.80−0.28 (-9.09%)
Close on Nov 13, 2026Market cap $334.43MP/E –Yield –
Accuray ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Accuray's ebitda for the twelve months ending Sep 30, 2026 was -$43.34M, down 960.4% year over year. For fiscal 2026 it was -$18.50M, down 232.2% from the year before. The highest annual figure on record is $28.62M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$18.50M | -232.2% |
| FY2025 | Jun 30, 2025 | $13.99M | +118.3% |
| FY2024 | Jun 30, 2024 | $6.41M | -7.2% |
| FY2023 | Jun 30, 2023 | $6.91M | -49.4% |
| FY2022 | Jun 30, 2022 | $13.66M | -52.3% |
| FY2021 | Jun 30, 2021 | $28.62M | +42.5% |
| FY2020 | Jun 30, 2020 | $20.08M | +81.3% |
| FY2019 | Jun 30, 2019 | $11.07M | +86.6% |
| FY2018 | Jun 30, 2018 | $5.94M | -27.8% |
| FY2017 | Jun 30, 2017 | $8.22M | -38.8% |
| FY2016 | Jun 30, 2016 | $13.42M | +4042.9% |
| FY2015 | Jun 30, 2015 | $324.00K | -86.6% |
| FY2014 | Jun 30, 2014 | $2.42M | – |
| FY2013 | Jun 30, 2013 | -$55.09M | – |
| FY2012 | Jun 30, 2012 | -$23.64M | – |
| FY2011 | Jun 30, 2011 | -$20.26M | -303.5% |
| FY2010 | Jun 30, 2010 | $9.96M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$34.48M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $7.55M | +29.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$7.01M | -367.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$9.40M | -251.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$9.64M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $5.83M | -29.9% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.62M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $6.22M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$685.00K | -119.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $8.32M | +1200.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$2.96M | -186.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$2.42M | -162.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $3.46M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $640.00K | -80.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $3.42M | +207.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $3.86M | -28.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$1.01M | -126.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $3.32M | -41.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.11M | -81.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $5.40M | -45.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $3.83M | -46.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $5.64M | -21.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $6.00M | -39.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $9.86M | +80.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $7.13M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $7.19M | -6.2% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $9.84M | +105.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $5.47M | +364.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$2.42M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $7.66M | +40.9% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $4.80M | +937.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.18M | -83.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$2.56M | -177.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $5.44M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $462.00K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $7.01M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $3.30M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$198.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$1.89M | – |
See a number that looks wrong?